Risk Factors for Gastrointestinal Side Effects from GLP-1RAs in Diabetes Patients
Author Information
Author(s): Gao Rui, Li Yue, Li Anan, Zhou Penglin, Zong Huiying, Li Yan
Primary Institution: The First Affiliated Hospital of Shandong First Medical University, Jinan, China
Hypothesis
What are the risk factors for gastrointestinal side effects in patients with type 2 diabetes treated with GLP-1 receptor agonists?
Conclusion
The study established a nomogram model that effectively predicts gastrointestinal side effects in patients with type 2 diabetes using GLP-1 receptor agonists.
Supporting Evidence
- Age, gender, history of gastrointestinal disorders, and number of combined oral medications were identified as risk factors for gastrointestinal side effects.
- The nomogram model showed good discriminability with AUC values of 0.855 and 0.836 for training and validation sets, respectively.
- Decision curve analysis indicated that the model had clinical utility for predicting gastrointestinal side effects.
Takeaway
This study found that certain factors like age and previous stomach issues can make diabetes patients more likely to have tummy troubles when taking specific diabetes medications.
Methodology
855 patients were analyzed using multifactorial logistic regression to identify risk factors for gastrointestinal side effects and to develop a nomogram prediction model.
Potential Biases
Documentation of gastrointestinal side effects was based on medical records, which may contain factual bias.
Limitations
The study is cross-sectional and lacks long-term follow-up data, which may introduce confounding factors.
Participant Demographics
The study included 855 patients, predominantly men (72.98%), with an average age of 54 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website